Marshall Wace, LLP Lannett CO Inc Put Options Transaction History
Marshall Wace, LLP
- $77.3 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding LCI
# of Institutions
1Shares Held
0Call Options Held
0Put Options Held
0About LANNETT CO INC
- Ticker LCI
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 42,960,000
- Market Cap $1.29M
- Description
- Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...